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Abstract
Background: Imaging studies of bones in patients with sensory deficits are scarce.
Aim: To investigate bone MR images of the lower limb in diabetic patients with severe sensory polyneuropathy, and in 
control subjects without sensory deficits.
Methods: Routine T1 weighted and T2-fat-suppressed-STIR-sequences without contrast media were performed of the 
asymptomatic foot in 10 diabetic patients with polyneuropathy and unilateral inactive Charcot foot, and in 10 matched 
and 10 younger, non-obese unmatched control subjects. Simultaneously, a Gadolinium containing phantom was also 
assessed for reference. T1 weighted signal intensity (SI) was recorded at representative regions of interest at the 
peritendineal soft tissue, the tibia, the calcaneus, and at the phantom. Any abnormal skeletal morphology was also 
recorded.
Results: Mean SI at the soft tissue, the calcaneus, and the tibia, respectively, was 105%, 105% and 84% of that at the 
phantom in the matched and unmatched control subjects, compared to 102% (soft tissue), 112% (calcaneus) and 64% 
(tibia) in the patients; differences of tibia vs. calcaneus or soft tissue were highly significant (p < 0.005). SI at the tibia 
was lower in the patients than in control subjects (p < 0.05). Occult traumatic skeletal lesions were found in 8 of the 10 
asymptomatic diabetic feet (none in the control feet).
Conclusion: MR imaging did not reveal grossly abnormal bone marrow signalling in the limbs with severe sensory 
polyneuropathy, but occult sequelae of previous traumatic injuries.
Introduction
Neuro-osteoarthropathy of the feet, i.e. the Charcot foot
in diabetes, is believed to be caused either by repeat trau-
matisation of an injured insensitive foot [1,2], or by a
hypothetical neurogenic bone dystrophy [2,3], or both.
Hence, the „diabetic“ Charcot foot might be caused by a
specific osteopathy, or by an „abnormal“ reaction of the
„diabetic bone“ to simple mechanical stress [4]. While it
is undisputed that a most severe loss of protective sensa-
tion, and of pain sensation in particular [5], is a necessary
prerequisite for a Charcot foot to develop, bone abnor-
malities consistent with a neuropathic osteopathy so far
have not been demonstrated convincingly. Direct histo-
morphometric bone analyses-apart from animal studies-
are lacking; there are only few, albeit crude, histopatho-
logical data from human studies available [6]. Studies
assessing bone mineral density (BMD) in diabetic neu-
ropathy have yielded conflicting results, due to problems
with patient selection and methodology [2]. Foot BMD is
increased in Type-2 diabetes mellitus (most likely in rela-
tion to the increased prevalence of overweight in this
patient population), whereas in Type-1 diabetes mellitus,
it is slightly reduced (-5% compared to control subjects),
most likely due to insufficient IGF-1 generation in this
population [7]. Bone morphology studies with X-ray and
other imaging techniques have rarely been published [8-
11]. We therefore set up an MR imaging study of the cal-
caneal and tibial bone in patients with most severe dia-
betic neuropathy, i.e. in diabetic patients with a history of
unilateral, healed Charcot foot, and in matched and non-
matched healthy control subjects. In extension of our
previous work on symptomatic Charcot feet [12], we used
the contralateral (asymptomatic) non-Charcot foot for
the present investigation.* Correspondence: chantelau@gmx.de
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Patients
Diabetic patients (n = 10) with unilateral, healed Charcot-
foot, chronic inactive for at least 1 year, were recruited
from the outpatient diabetic foot clinic at the Heinrich-
Heine-University of Düsseldorf. All patients displayed
severe peripheral sensory polyneuropathy (vibration sen-
sation at the first metatarsal head < 4/8 grades by Rydel-
Seiffer tuning fork [13]). At the time of the study they
were free of active foot ulceration, relapse or re-activation
of the Charcot-foot. Two of the patients had endstage
renal disease with kidney transplantation (n = 1), or
hemodialysis (n = 1).
Control subjects
Healthy matched controls (n = 10) were recruited from
relatives of the staff of the traumatology clinic in Duis-
burg-Buchholz (Berufsgenossenschaftliche Unfallklinik
Duisburg GmbH/Germany). They were eligible if they
did not have diabetes mellitus (according to self-reported
absence of antidiabetic medication), and if they matched
to the patients' age (+/- 5 years), body mass index (+/- 1
kg/m2), and gender.
Another group (n = 10) of younger (60 years and less)
and less overweight (BMI <28 kg/m2) healthy unmatched
control subjects was also studied.
The clinical characteristics of the participants are sum-
marised in Table 1.
Body mass index (BMI) was calculated using self-
reported weight (kg) and height (m); a BMI > 28 kg/m2
was assumed to indicate relevant overweight.
Examinations
Routine MR examinations were performed on a 1.5 Tesla
superconducting magnet (Magnetom Avanto, Siemens).
Subjects were examined in supine position, placing the
feet first into the gantry. All examinations were per-
formed with a head-neck surface coil. Contrast media
was not applied to the study participants. Each foot was
scanned in sagittal view using T1-weighted turbo-spin-
echo (TSE) sequences (TR: 580, TE: 15) with a slice thick-
ness of 3 mm. Paracoronal T1-weighted TSE-sequences
were acquired parallel to the midfoot through tibia, calca-
neus und talus. Sagittal T2-fat-suppressed-STIR-
sequences (TR: 3200, TE: 27, TI 160 msec) were also
acquired [14]. Paracoronal T1-weighted TSE-sequences
und STIR-sequences were acquired parallel to the mid-
foot and an axial T2-weighted-fat-suppressed sequence
was performed through tibia, calcaneus und talus. Total
examination time was about 40 minutes. All MR exami-
nations had diagnostic quality and were well tolerated by
all patients; they were carried out by an experienced mus-
culoskeletal radiologist (L.W.P.).
To account for day-to-day variations in the sensitivity
of the coil, a phantom prepared with contrast media
(Gadolinium) was repeatedly subjected to MRI together
with the feet; its signal intensity - assessed as described
below- was highly reproducible (coefficient of variation
3.7%).
Signal intensity
Signal intensity was assessed on sagittal T1-weighted TSE
sequences. To this end, on the main console of the mag-
Table 1: clinical characteristics and MRI findings
diabetic patients matched controls non-matched, non-diabetic, younger controls
number(f/m) 10(5/5) 10(5/5) 10(4/6)
diabetes type-1, n 3 0 0
diabetes type-2, n 7 0 0
duration of diabetes, yrs 24(20-27) 0 0
age, yrs 59(53-65) 58(52-64) 45(37-53)
body mass index, kg/m2 29(26-33) 28(26-30) 25(23-27)
polyneuropathy, n 10 0 0
MRI skeletal damage, n 8 0 0
T1 weighted SI in% of phantom SI
..soft tissue 102(80-126) 104(99-109) 105(101-110)
..calcaneus 112(100-123) 102(96-108) 107(102-112)
..tibia* 64(49-80)** 85(76-93) 82(77-86)
SI = signal intensity; means (95% confidence intervals),*p < 0.005 versus calcaneus and soft tissue, respectively;** p < 0.05 versus tibia in 
controls
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electronically. Circular regions of interest of 0.5-1.5 cm
diameter - as appropriate- were positioned at the distal
part of the tibia, at the centre of the calcaneus, at the
adjacent soft tissue underneath the achilles tendon (Fig-
ure 1), and at the contrast media container. Signal inten-
sity (expressed in arbitrary units) assessments were
highly reproducible (coefficient of variation < 4%), irre-
spective of the ROI size. Assessments were performed in
duplicate one week apart with repositioning of the ROIs,
with a third assessment being made if the two means dif-
fered by 5% or more, and the means were averaged. High
SI indicates fat, low SI indicates water [15].
Calculations
Bone and soft tissue signal intensity was analysed as per-
centage of the mean signal intensity of the Gadolinium
phantom.
Ethics
All subjects gave written informed consent. The study
was approved by the ethical committee of the medical
faculty of the Heinrich-Heine-University of Düsseldorf/
Germany (Study Nr 2717).
Statistics
Data are presented as means with 95% confidence inter-
vals, and processed for descriptive purposes only. Stu-
dent's t-test was applied with p < 0.05 as level of
significance.
Results
In the matched control subjects, SI at the peritendineal
soft tissue, the calcaneus, and the tibia, respectively, was
104%, 102% and 85% of that at the phantom, compared to
105%, 107% and 82% in the non-matched controls, and
102% (soft tissue), 112% (calcaneus) and 64% (tibia) in the
neuropathic patients. SI was significantly lower at the
tibia (than at the calcaneus or peritendineal soft tissue) in
all three subject groups (p < 0.005); SI at the tibia was
lower in the neuropathic patients than in control subjects
(p < 0.05) (see Table 1). In 8 of the 10 clinically asymp-
tomatic feet of the neuropathic patients, occult residual
traumatic lesions were found (stress injuries in 2 cases,
healed ankle fracture in 1 case, healed metatarsal shaft
fracture in 1 case, ruptured Achilles tendon in 1 case,
osteochondrosis dissecans in 2 cases, activated arthrosis
in 2 cases); in 6 of these cases, injuries (e.g. painful
events) were not recalled by the patients. Non-traumatic
lesions were found in 6 cases (bone cyst (n = 4), and cal-
caneal spur (n = 2)). None of the control subjects dis-
played any skeletal abnormalities.
Discussion
The present data show that routine MR imaging [16] may
not reveal grossly abnormal bone marrow signalling in
the limbs with severe sensory polyneuropathy, but occult
sequelae of previous traumatic injuries.
T1 weighted signal intensity at the bone-indicative of
marrow fat [15,17] - was generally lower at the distal tibia
than at the calcaneus (p < 0.005). Hence, the relative con-
tent of fat seems to be greater in the calcaneus than in the
tibia. Interestingly, these findings parallel differences in
bone mineral density (BMD) obtained by dual X-ray
absorptiometry: BMD is only half as much in the calca-
neus than in the femur (approximately 0.5 g/cm2 versus
0.9 g/cm2)[18]. BMD at the foot skeleton may be similar
in subjects with and without diabetic polyneuropathy
[9,18,19]. BMD at the tibia (approximately 1.0 g/cm2) may
be similar in subjects with and without diabetic polyneu-
ropathy and a history of unilateral Charcot foot [20]. The
signal intensity at the tibia was significantly lower in the
patients than in the controls; we have no explanation for
this.
The present study found occult traumatic bone injuries
in 80% of the asymptomatic feet in the diabetic patients
with polyneuropathy, although these had not been
reported by the patients. In general, recent traumatic
events (from ankle sprains, hitting objects in the living
room, or overuse [21]) are rarely recalled precisely by
elderly subjects [22], and less so by subjects with sensory
deficits. A MRI-based study in asymptomatic feet of
patients with peripheral sensory nerve dysfunction from
leprosy has found residual lesions of prior traumatic inju-
ries in 4 out of 6 of cases (67%) [11], whereas a previous
X-ray based study has observed such lesions in 22% of 54
asymptomatic feet with diabetic polyneuropathy [8]. MRI
is more sensitive than X-ray to detect traumatic skeletal
lesions [23]. Therefore, the higher prevalence of trau-
matic lesions in MRI-based studies may represent the
true prevalence of traumatic injuries (e.g. from sprains, or
stress impacts) in asymptomatic feet of patients with
peripheral sensory nerve dysfunction. Recent epidemio-
logic studies seem to support this assumption: diabetes
mellitus of long duration is an established risk factor for
foot fractures [24]. Moreover, increased foot loading e.g.
from obesity increases the risk of foot fractures [25], and
of Charcot-foot deformities in diabetic neuropathy in
particular [26,27].
Our study has strengths and weaknesses. Its strength is
the fact that-to the best of our knowledge-it is the first
study to assess bone morphology in asymptomatic feet
with diabetic polyneuropathy by MRI. It is a weakness,
however, that the sample size is only small, that self-
reported data were used, and that the patient population
was rather heterogeneous (2 of 10 patients had chronic
kidney failure, 3 of the 10 patients had type-1 diabetes
mellitus). Hence, our study sample was not appropriate to
draw definite conclusions. Moreover, only routine MRI-
techniques were employed that do not correlate well with
established surrogate parameters of bone strength
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additional insights into the bone structure in diabetic
neuropathy [30-33].
In conclusion, routine MR imaging did not reveal
grossly abnormal bone marrow signalling in the limbs
with severe sensory polyneuropathy, but a high preva-
lence of occult sequelae of previous traumatic injuries.
According to these preliminary observations, a hypothet-
ical endogenous osteopathy is unlikely. More specific
MRI analyses, e.g. by MR histomorphometry are war-
ranted to corroborate these findings in patients with dia-
betic polyneuropathy.
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Figure 1 Sagittal T1-TSE-Sequence of a right foot, with regions of interest (ROI) deliberately placed in peritendineal soft tissue (1), distal 
tibia (2), and calcaneus (3).
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